Home › Funds › Cormorant Asset Management, LP › EWTX
Cormorant Asset Management, LP position in EWTX
EDGEWISE THERAPEUTICS INC · Health Care
Cormorant Asset Management, LP reported holding 1,860,000 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$75.5M, representing 5.40% of its reported portfolio and ranking #4 among its reported holdings. Cormorant Asset Management, LP has disclosed EWTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's EWTX position evolved
Cormorant Asset Management, LP first disclosed a stake in EWTX in Q3 2023 at 2,946,887 shares (US$16.9M). The position peaked in Q1 2026 at 3,260,000 shares, worth US$102.7M. Across 13 filings, Cormorant Asset Management, LP increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,860,000 shares valued at US$75.5M — a reduction of -650,000 shares quarter over quarter.. Notable position changes include a 26% trim in Q3 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.95M | $16.89M | New |
| Q4 2023 | 2.55M | $27.92M | Reduce |
| Q1 2024 | 3.01M | $54.84M | Add |
| Q2 2024 | 3.01M | $54.15M | Hold |
| Q3 2024 | 3.41M | $90.92M | Add |
| Q4 2024 | 3.41M | $90.95M | Hold |
| Q1 2025 | 4.10M | $90.24M | Add |
| Q2 2025 | 4.25M | $55.74M | Add |
| Q3 2025 | 4.01M | $65.04M | Reduce |
| Q4 2025 | 3.29M | $81.52M | Reduce |
| Q1 2026 | 3.26M | $102.69M | Reduce |
| Q2 2026 | 2.51M | $101.98M | Reduce |
| Q3 2026 | 1.86M | $75.52M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EWTX and 13F data
EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.1M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$340.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EWTX
- ORBIMED ADVISORS LLC 15.52M sh · $630.05M · Q3 2026
- Paradigm Biocapital Advisors LP 10.78M sh · $437.61M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M sh · $340.74M · Q3 2026
- Novo Holdings A/S 5.35M sh · $217.21M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.40M sh · $178.72M · Q3 2026
- PERCEPTIVE ADVISORS LLC 4.14M sh · $168.01M · Q3 2026
- BAKER BROS. ADVISORS LP 3.70M sh · $150.29M · Q3 2026
- Siren, L.L.C. 2.80M sh · $113.85M · Q3 2026
- First Light Asset Management, LLC 2.48M sh · $100.81M · Q3 2026
- BRAIDWELL LP 2.07M sh · $84.01M · Q3 2026
- MPM BioImpact LLC 1.58M sh · $63.99M · Q3 2026
- Deep Track Capital, LP 1.15M sh · $46.64M · Q3 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held EWTX?
Cormorant Asset Management, LP has disclosed EWTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Cormorant Asset Management, LP's current position in EWTX?
As of Q3 2026, Cormorant Asset Management, LP holds 1.86M shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $75.52M, representing 5.40% of its reported portfolio and ranking #4.
Has Cormorant Asset Management, LP been buying or selling EWTX?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP reduced its position in EWTX. The position peaked in Q1 2026 at 3.26M shares.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.